Evidence map›Paper›PMID 38644369›Full record

ArticleScientific reports2024

Dynamics of CD44

J R Ferreira, J Caldeira, M Sousa, M A Barbosa, M Lamghari, G Almeida-Porada, R M Gonçalves

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

J R FerreiraI3S-Instituto de Investigação e Inovação em Saúde, Universidade Do Porto, Porto, Portugal.
J CaldeiraI3S-Instituto de Investigação e Inovação em Saúde, Universidade Do Porto, Porto, Portugal.
M SousaI3S-Instituto de Investigação e Inovação em Saúde, Universidade Do Porto, Porto, Portugal.
M A BarbosaI3S-Instituto de Investigação e Inovação em Saúde, Universidade Do Porto, Porto, Portugal.
M LamghariI3S-Instituto de Investigação e Inovação em Saúde, Universidade Do Porto, Porto, Portugal.
G Almeida-PoradaWFIRM-Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA.
R M GonçalvesI3S-Instituto de Investigação e Inovação em Saúde, Universidade Do Porto, Porto, Portugal. raquelg@i3s.up.pt.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTUniversidade do Porto · PTWake Forest University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intervertebral Disc (IVD) degeneration has been associated with a chronic inflammatory response, but knowledge on the contribution of distinct IVD cells, namely CD44, to the progression of IVD degeneration remains elusive. Here, bovine nucleus pulposus (NP) CD44 cells were sorted and compared by gene expression and proteomics with the negative counterpart. NP cells were then stimulated with IL-1b (10 ng/ml) and dynamics of CD44 gene and protein expression was analyzed upon pro-inflammatory treatment. The results emphasize that CD44 has a multidimensional functional role in IVD metabolism, ECM synthesis and production of neuropermissive factors. CD44 widespread expression in NP was partially associated with CD14 and CD45, resulting in the identification of distinct cell subsets. In conclusion, this study points out CD44 and CD44-based cell subsets as relevant targets in the modulation of the IVD pro-inflammatory/degenerative cascade.

Indexed as

Hyaluronan ReceptorsInflammationIntervertebral Disc DegenerationNucleus PulposusAnimalsCattleCells, CulturedInterleukin-1betaProteomicsHyaluronan ReceptorsInterleukin-1betaCD44IL-1βInflammationIntervertebral discProteomics

Identifiers

PMID38644369
PMCPMC11033282
OpenAlexW4394989517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.